Anti-colorectal cancer effects of scutellarin revealed by genomic and proteomic analysis

被引:18
|
作者
Xiong, Liu-Lin [1 ,3 ,4 ]
Du, Ruo-Lan [1 ,2 ]
Xue, Lu-Lu [2 ]
Jiang, Ya [2 ]
Huang, Jin [2 ]
Chen, Li [1 ]
Liu, Jia [2 ]
Wang, Ting-Hua [1 ,2 ]
机构
[1] Sichuan Univ, Inst Neurol Dis, West China Hosp, Translat Neurosci Ctr, Chengdu 610041, Peoples R China
[2] Kunming Med Univ, Inst Neurosci, Anim Zool Dept, Kunming 650000, Yunnan, Peoples R China
[3] Zunyi Med Univ, Affiliated Hosp, Dept Anesthesiol, Zunyi 563000, Guizhou, Peoples R China
[4] Univ South Australia, Sch Pharm & Med Sci, Div Hlth Sci, Adelaide, SA, Australia
基金
中国国家自然科学基金;
关键词
Colorectal cancer; Scutellarin; Antitumor effect; Genomics; proteomics; TRADITIONAL CHINESE MEDICINE; CELL-PROLIFERATION; FAMILY-HISTORY; APOPTOSIS; ANGIOGENESIS; MIGRATION; GROWTH;
D O I
10.1186/s13020-020-00307-z
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Background Colorectal cancer, one of the most common digestive tumors with high mortality and morbidity worldwide, currently lacks effective therapies available to improve the prognosis. This study was aimed to investigate the potency of Scutellarin against colorectal cancers, and explore the related mechanism via genomic and proteomic analysis. Methods Cell counting kit-8 assay was employed to detect the viability of HCT-116 and RKO cell lines treated with Scutellarin. The apoptosis of HCT-116 and RKO cells after Scutellarin administration was determined by TUNEL staining and Caspase 3/7 activity. Cell cycle was detected by flow cytometry analysis. The wound healing and transwell invasion test detected the role of Scutellarin in migration and invasion of HCT-116 and RKO cells. Meanwhile, the energy metabolism and growth of tumor tissues in vivo at day 28 were observed by PET-CT after Scutellarin administration with 50 mg/kg, 100 mg/kg and 300 mg/kg into 4-week-old nude mice. Blood routine and liver functions were also detected to evaluate the side effect of Scutellarin. Furthermore, the disease and function classifications which the differentially expressed genes and proteins involved after Scutellarin treatment were determined by genomic and proteomic analysis respectively. Results The Scutellarin inhibited the migration and increased apoptosis of HCT-116 and RKO cell lines. Besides, Scutellarin treatment substantially decreased the growth and volume of colorectal tumors in nude mice without side effects on the blood routine and liver function. The differentially expressed genes in RKO cells after Scutellarin administration were mainly enriched in cell death and survival, organismal injury and abnormalities, and cancer. In addition, forty-seven upregulated and twenty-nine downregulated proteins were identified. Functional clustering analysis exhibited enriched biological processes, cellular components, molecular functions and related pathways of these proteins in cellular metabolic. Then protein-protein interactions analysis showed the regulatory relationship among these differentially expressed proteins. Conclusions Taken together, the present findings revealed that Scutellarin exerted significant antitumor effect with no side effects in the blood and liver by regulating various important molecules in tumor proliferation, apoptosis and metastasis.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] Anti-Colorectal Cancer Activity of Panax and Its Active Components, Ginsenosides: A Review
    Kang, Han Su
    Lim, Hyun Kyung
    Jang, Won Young
    Cho, Jae Youl
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (06)
  • [32] Anti-colorectal cancer biotargets and biological mechanisms of puerarin: Study of molecular networks
    Li, Jun
    Guo, Chao
    Lu, Xiuli
    Tan, Wenwen
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2019, 858
  • [33] Synthetic derivatives of natural cinnamic acids as potential anti-colorectal cancer agents
    Falbo, Federica
    Gemma, Sandra
    Koch, Adrian
    Mazzotta, Sarah
    Carullo, Gabriele
    Ramunno, Anna
    Butini, Stefania
    Schneider-Stock, Regine
    Campiani, Giuseppe
    Aiello, Francesca
    CHEMICAL BIOLOGY & DRUG DESIGN, 2024, 103 (01)
  • [34] Curcumin-loaded polymeric nanoparticles for enhanced anti-colorectal cancer applications
    Udompornmongkol, Panisa
    Chiang, Been-Huang
    JOURNAL OF BIOMATERIALS APPLICATIONS, 2015, 30 (05) : 537 - 546
  • [35] Molecular Docking Studies of Glycyrrhetinic Acid Derivatives as Anti-Colorectal Cancer Agents
    Doan, Nam Q. H.
    Truong, Tuyen N.
    Nguyen, Phuong T. V.
    CURRENT COMPUTER-AIDED DRUG DESIGN, 2021, 17 (03) : 429 - 444
  • [36] Synthesis and Cytotoxicity Assay of Aniline Substituted Thienopyrimidines for Anti-Colorectal Cancer Activity
    Biradar, Mahalakshmi Suresha
    Nargund, Shachindra L.
    Thapa, Shankar
    RESULTS IN CHEMISTRY, 2023, 5
  • [37] Expression of a prototypic anti-colorectal cancer polyclonal antibody library in mammalian cells
    Chen, LY
    Liebman, MA
    Teodorescu-Frumosu, S
    Schnitzler, AC
    Sharon, J
    IMMUNOLOGY LETTERS, 2003, 88 (02) : 135 - 140
  • [38] Colorectal Cancer Biomarkers Discovery Approach: A Proteomic and Genomic Perspective
    Al-Zahrani, Maryam Hassan
    JOURNAL OF BIOCHEMICAL TECHNOLOGY, 2023, 14 (03) : 6 - 12
  • [39] Integrated epidemiologic, genomic proteomic approach to colorectal cancer.
    Gruber, SB
    Rennert, G
    Bonner, JD
    Sprecher, B
    Lee, N
    Misek, DE
    Kuick, R
    Tomsho, LP
    Kardia, SR
    Taylor, JM
    Giordano, TJ
    Greenson, JK
    Hanash, SM
    Fearon, ER
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2001, 153 (11) : S96 - S96
  • [40] Glycomodification and characterization of anti-colorectal cancer immunotherapeutic monoclonal antibodies in transgenic tobacco
    Yangkang So
    Kyung-Jin Lee
    Deuk-Su Kim
    Jeong-Hwan Lee
    Doo-Byoung Oh
    Kyung-A Hwang
    Kinarm Ko
    Young-Kug Choo
    Kisung Ko
    Plant Cell, Tissue and Organ Culture (PCTOC), 2013, 113 : 41 - 49